Filing Details

Accession Number:
0001237899-12-000074
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-04 13:22:12
Reporting Period:
2012-08-31
Filing Date:
2012-09-04
Accepted Time:
2012-09-04 13:22:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226435 A Murray Goldberg 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Finance And Admin Cfo Trea No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-07-27 600 $0.00 95,810 No 5 G Direct
Common Stock Disposition 2012-08-31 503 $144.59 95,307 No 4 S Direct
Common Stock Disposition 2012-08-31 2,691 $145.60 92,616 No 4 S Direct
Common Stock Disposition 2012-08-31 1,626 $146.37 90,990 No 4 S Direct
Common Stock Disposition 2012-08-31 476 $147.21 90,514 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,560 Indirect By 401(k) Plan
Footnotes
  1. Gift of Common Stock to charitable organization.
  2. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  3. Represents volume-weighted average price of sales of 503 shares of Company stock on August 31, 2012 at prices ranging from $144.00 to $144.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.
  4. Represents volume-weighted average price of sales of 2,691 shares of Company stock on August 31, 2012 at prices ranging from $145.03 to $145.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.
  5. Represents volume-weighted average price of sales of 1,626 shares of Company stock on August 31, 2012 at prices ranging from $146.06 to $146.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.
  6. Represents volume-weighted average price of sales of 476 shares of Company stock on August 31, 2012 at prices ranging from $147.10 to $147.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.